Key result
Managing vascular risk factors such as hypertension, diabetes, and hypercholesterolemia may have potential value in slowing disease progression in Alzheimer's disease patients.
Why the study?
Does the treatment of vascular risk factors slow cognitive decline in Alzheimer's disease patients?
Does the treatment of vascular risk factors slow cognitive decline in Alzheimer's disease patients?
This review highlights the potential value of managing vascular risk factors to slow the progression of Alzheimer's disease.
Supports vascular risk factor management in Alzheimer's; leaves open whether it slows cognitive decline without prospective trials.
Dementia is a widespread disorder with major medical, economic and societal costs. Controlling vascular conditions could be one way of delaying the progression of Alzheimer's disease (AD). In fact, vascular risk factors are implicated in AD occurrence. However, it has not been clearly determined whether these vascular factors also affect disease progression itself and thus whether controlling vascular conditions can slow this progression. The treatment of vascular risk factors could have an impact on disease progression by slowing the development of the vascular component. In the present article, we review the potential value of managing hypertension, diabetes, hypercholesterolemia or global vascular risk factors in AD patients.
No takes yet. Share an insight, caveat, or question.
Richard et al. (2012) conducted a review in Alzheimer's disease. Management of vascular risk factors (hypertension, diabetes, hypercholesterolemia) was evaluated on Disease progression / cognitive decline. Managing vascular risk factors such as hypertension, diabetes, and hypercholesterolemia may have potential value in slowing disease progression in Alzheimer's disease patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: